May
6
2021
On demand

From first collection to commercial launch: Streamlining your supply chain to support next generation therapies

With the surge of innovative cell and gene therapies moving to market, commercial readiness is crucial to successfully delivering these therapies to waiting patients.

As your therapy operations move from early-phase clinical trials to larger populations in late-stage trials and commercialization, your supply chain complexity—and risk—increases. Anticipating common setbacks and actively planning for their solution requires a specialized and collaborative approach with your supply chain partner.

Attend this upcoming webinar for expert insights into strategies that aid in the development of a commercial supply chain for emerging autologous and allogeneic therapies.

  • Proven supply chain strategies that have supported the successful commercial launch of cell and gene therapies 
  • Keys to forming and maintaining successful collaborations in cell therapy starting material procurement and management 
  • The importance of leveraging partners that have historical expertise and offer comprehensive support across the commercial supply chain 
  • Decisions made during clinical development to help anticipate challenges at each phase of advancement and streamline commercialization

Chris McClain

Head of Business Development & Sales, Be The Match BioTherapies

Chris McClain is the Senior Vice President of Sales and Business Development for Be The Match BioTherapies. He leads the sales and business development team, which engages with companies developing innovative, lifesaving therapies that can leverage the cell sourcing, cell therapy supply chain, CRO services, and outcomes tracking capabilities of the National Marrow Donor Program (NMDP) / Be The Match.

Before joining Be the Match BioTherapies full-time, Chris was co-Founder of Nora Therapeutics, Inc., a venture-backed biopharmaceutical company developing novel therapies in areas of significant unmet medical need in reproductive health. While at Nora Therapeutics, Chris and his team raised more than $50 million in venture capital to fund pre-clinical and clinical development of Nora’s lead asset and build out a world-class executive team. Prior to founding Nora Therapeutics, Chris held a variety of management consulting and operational roles in the technology sector.

He has served as an advisory member of the University of Minnesota Office for Technology Commercialization Venture Center, a guest lecturer in the Life Sciences program at the University of Minnesota’s Carlson Graduate School of Management, a mentor to the annual MNCup startup competition, and a co-chair of Medical Alley’s Biotech Shared Interest Group.

Chris has an MBA and B.A. in Economics from the University of California, Berkeley.

Aileen Baquiran

Vice President, Global Supply Chain and Business Operations, Orchard Therapeutics

Aileen Baquiran is the Vice President of Global Supply Chain and Business Operations for Orchard Therapeutics. Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by rare diseases through the development of innovative, potentially curative hematopoietic stem cell gene therapies. In her role as head of supply chain, she is responsible for Sales and Operations Planning (S&OP), clinical and commercial site qualification, and global distribution.

Aileen has over 20 years of experience in the life sciences industry. Prior to Orchard, she held supply chain management and project management roles at Dermira, Jazz Pharmaceuticals and Johnson & Johnson. Aileen earned her BS degree in Industrial Engineering from Cal Poly, San Luis Obispo and MBA from the University of San Francisco.

SPEAKERS

Chris McClain
Head of Business Development & Sales at Be The Match BioTherapies
Aileen Baquiran
Senior Director, Business Operations

You might also like

Strategic supply chain design: flexibility and scalability considerations for...

N Kulkarni, PhD
G Linton, RA, AIA, LEED AP BD+C
Niranjan Kulkarni, PhD
Niranjan Kulkarni, PhD
Senior Director, Consulting Services at CRB
Grace Linton, RA, AIA, LEED AP BD+C
Grace Linton, RA, AIA, LEED AP BD+C
Director of Process Architecture at CRB
28 April 2022
Watch now

Supply chain efficiency and sourcing for scaling your gene therapy operation

C Martin
D Young
Céline  Martin
Céline Martin
Senior Product Manager, Gene Therapy at Thermo Fisher Scientific
Don Young
Don Young
Senior Global Product Manager, Single-Use Technologies at Thermo Fisher Scientific
7 April 2022
Watch now

Rapid translation of a cellular therapeutic: Choosing product & process development...

A Patel
J Candiello
Ashish Patel
Ashish Patel
Clinical Senior Lecturer and Consultant Vascular and Endovascular Surgeon at Foundation for the National Institutes of Health
Joseph Candiello
Joseph Candiello
Senior Product Manager at RoosterBio Inc
10 March 2022
Watch now

Cell and gene therapy matures: Streamlining and smoothing the path to commercialization

M Hewitt
Matt Hewitt, PhD
Matt Hewitt, PhD
Senior Director, Scientific Services, Cell and Gene Therapy, Charles River Laboratories
11 January 2022
Watch now

Considerations for developing scalable and efficient collection network processes

L Anderson,
S Butler,
A Montalvo
Lacey Anderson
Lacey Anderson
Senior Manager, Collection Network Management, Be The Match BioTherapies
Sara Butler
Sara Butler
Network Liaison, Be The Match BioTherapies
Allison Montalvo,
Allison Montalvo,
Program Manager, Oncology, Janssen ( A division of J&J)
28 October 2021
Watch now